Rydex Biotechnology Fund (RYOIX)
Under normal circumstances, the fund invests substantially all (at least 80%) of its net assets in equity securities of Biotechnology Companies that are traded in the United States and in derivatives, which primarily consist of futures contracts and options on securities, futures contracts, and stock indices. It may invest to a significant extent in the securities of Biotechnology Companies that have small to mid-sized capitalizations.
Fund Info
US7835548279
783554827
Mar 31, 1998
$2,500
Mid-Cap
Blend
Expense Ratio
RYOIX has a high expense ratio of 1.36%, indicating higher-than-average management fees.
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in Rydex Biotechnology Fund, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
Rydex Biotechnology Fund had a return of 6.78% year-to-date (YTD) and -7.21% in the last 12 months. Over the past 10 years, Rydex Biotechnology Fund had an annualized return of -2.80%, while the S&P 500 had an annualized return of 11.31%, indicating that Rydex Biotechnology Fund did not perform as well as the benchmark.
RYOIX
6.78%
6.46%
-16.64%
-7.21%
-4.07%
-2.80%
^GSPC (Benchmark)
4.46%
2.46%
9.31%
23.49%
13.03%
11.31%
Monthly Returns
The table below presents the monthly returns of RYOIX, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | 5.41% | 6.78% | |||||||||||
| 2024 | -1.30% | 2.19% | -0.07% | -7.29% | 5.25% | 4.63% | 6.05% | 1.74% | -2.77% | -1.44% | 1.12% | -19.05% | -12.91% |
| 2023 | 2.26% | -4.48% | 0.13% | 1.79% | -2.56% | 0.93% | 0.94% | -0.46% | -4.30% | -6.10% | 6.19% | 12.98% | 6.06% |
| 2022 | -10.49% | -3.08% | 3.88% | -9.95% | -0.33% | -0.00% | 5.24% | -3.63% | -3.52% | 7.83% | 6.41% | -5.48% | -14.15% |
| 2021 | 5.28% | -2.16% | -4.42% | 4.33% | -3.40% | 9.21% | -1.55% | 3.76% | -5.22% | 0.25% | -4.43% | -15.27% | -14.83% |
| 2020 | -7.39% | -0.04% | -7.78% | 15.98% | 8.98% | 1.49% | 0.30% | -0.30% | 0.47% | -2.64% | 10.53% | -4.00% | 13.67% |
| 2019 | 14.23% | 3.82% | -0.11% | -5.58% | -6.06% | 8.62% | -3.40% | -3.79% | -1.53% | 6.79% | 12.27% | -4.27% | 19.88% |
| 2018 | 8.07% | -4.01% | -3.70% | -3.04% | 5.88% | 1.24% | 3.18% | 5.17% | -0.64% | -14.32% | 4.76% | -20.06% | -19.69% |
| 2017 | 6.08% | 6.94% | -0.94% | 2.60% | -3.85% | 9.21% | 2.22% | 4.75% | 1.27% | -3.30% | 1.17% | -4.22% | 23.01% |
| 2016 | -21.53% | -4.24% | 3.13% | 3.57% | 4.61% | -6.80% | 12.37% | -3.29% | 4.20% | -12.27% | 7.60% | -3.78% | -19.51% |
| 2015 | 6.07% | 5.67% | 1.64% | -4.18% | 11.28% | 0.96% | 3.77% | -11.53% | -12.20% | 6.24% | 2.57% | -0.46% | 7.23% |
| 2014 | 11.76% | 8.05% | -11.45% | -5.62% | 3.67% | 8.43% | -1.79% | 10.98% | -3.31% | 9.04% | -1.51% | -0.02% | 28.36% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current rank of RYOIX is 2, meaning it’s performing worse than 98% of other mutual funds on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Rydex Biotechnology Fund (RYOIX) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Worst Drawdowns
The table below displays the maximum drawdowns of the Rydex Biotechnology Fund. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Rydex Biotechnology Fund was 74.43%, occurring on Jul 10, 2002. Recovery took 2562 trading sessions.
The current Rydex Biotechnology Fund drawdown is 36.58%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -74.43% | Mar 7, 2000 | 584 | Jul 10, 2002 | 2562 | Sep 17, 2012 | 3146 |
| -45% | Jul 20, 2015 | 1739 | Jun 13, 2022 | — | — | — |
| -25.34% | May 14, 1998 | 78 | Aug 31, 1998 | 43 | Oct 29, 1998 | 121 |
| -23.25% | Feb 26, 2014 | 34 | Apr 14, 2014 | 134 | Oct 23, 2014 | 168 |
| -16.5% | Sep 10, 1999 | 27 | Oct 18, 1999 | 29 | Nov 26, 1999 | 56 |
Volatility
Volatility Chart
The current Rydex Biotechnology Fund volatility is 5.01%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.